Vanguard LifeStrategy 80/20 Fund Investor Shares VASGX

The Vanguard LifeStrategy series leverages a research-driven approach across four target risk portfolios that offer low-cost, broad-market asset allocation to align with varying risk appetites.

Vanguard’s centralized research and decision-making bodies promote consistency across all its multi-asset offerings. The firm’s investment strategy group produces much of the empirical research and thought leadership that drives this strategy. In addition, at least once per year, the strategic asset allocation committee formally reviews each portfolio’s strategic asset allocation and portfolio construction. The committee's 11 voting members, composed of senior leaders and investors across the firm, must approve substantial changes to the investment methodology, such as changing the percentage of equities invested in US stocks. As a result, portfolio changes are infrequent because of the group’s long-term focus and high standard for implementation.

The US funds target static equity exposures of 20%, 40%, 60%, and 80%, respectively. The portfolios’ equity sleeves have a 60% US/40% non-US stock split, while the bond sleeves have a 70% US/30% non-US bond split. The Ireland and UK-domiciled portfolios target the same static equity exposures. The UK portfolios make a 25% investment in UK equities and a 35% allocation in UK bonds, while the Ireland portfolios do not have an intentional home bias. The UK portfolios will reduce their domestic equity and bond allocations to 20% in March 2026.

The strategy uses low-cost index funds to gain broad exposure to global stocks and bonds. For US-based investors, Vanguard Total Stock Market Index provides exposure to nearly every investable US stock and diversifies against stock-specific risk. For non-US stock exposure, Vanguard Total International Stock Index holds more than 8,000 names across international emerging and developed markets, weighted by market capitalization. The series' two bond funds, Vanguard Total Bond Market II Index and Vanguard Total International Bond Index II, exclusively used in the LifeStrategy and target retirement series, provide global investment-grade fixed-income exposure.

Ultimately, these funds provide inexpensive, globally diversified marketlike portfolios. As of Feb. 1, 2026, fees for the US funds have been lowered to 10 basis points, down from 11-14 basis points, placing them in the cheapest 5% of their respective Morningstar Category peers. The UCITS vehicles are priced about twice as much but are still cheaper than 90% of their respective competitors.

A consistent and utilitarian approach results in broadly diversified portfolios that should provide an edge over the long term, driving an Above Average Process rating.

The series' equity exposure starts at 20% in the most conservative portfolio, increasing in 20-percentage-point increments to the most aggressive portfolio, which allocates 80% to equities and 20% to fixed income. Vanguard's strategic asset allocation committee reviews each portfolio's allocations annually, leveraging research produced by the investment strategy group, whose thought leadership drives the decisions behind Vanguard's investment strategies.

Guided by global market-cap weightings, management’s approach offers broad exposure and diversification. It eschews tactical tilts, actively managed underlying funds, and niche asset classes, instead sticking with inexpensive, index-based exposure.

Vanguard continuously strives for incremental improvements in its sampling, indexing, and trading methods. In January 2021, for example, it expanded the rebalancing threshold to 200 basis points from 100 to reduce trading frequency. Another modification adopted in January 2025 reduced the size of a rebalancing trade from 100 basis points to 25 and allowed the portfolio management team to limit unnecessary rebalances in favor of letting markets correct on their own. Both changes reflect Vanguard’s intense focus on minimizing trading costs.

The portfolios vary by geographic breakdown and underlying funds based on the firm’s capital market assumptions and local market preferences and offerings. The Ireland-domiciled UCITS ETFs reflect the least geographical bias (versus a market-cap-weighted portfolio), with a 60% US/40% non-US stock split and a bond sleeve divided equally between US and non-US fixed income. The US funds target a 60% US/40% non-US stock split, while the bond sleeves have a 70% US/30% non-US bond split. In March 2026, UK portfolios will reduce their home bias. UK equities will decrease to 20% of the equity sleeve from 25%, and domestic bonds will fall to 20% of fixed income from 35%.

The underlying strategies receive compelling Morningstar Medalist Ratings. The series' equity sleeve consists of Silver-rated Vanguard Total Stock Market Index and Gold-rated Vanguard Total International Stock Index (ratings as of January 2026). On the fixed-income side, the funds tap the clones of Vanguard Total Bond Index and Vanguard Total International Bond Index: Vanguard Total Bond Market II Index and Vanguard Total International Bond II Index, both rated Bronze. The bond funds are used exclusively in the LifeStrategy and the target retirement series, allowing Vanguard to separate transaction costs generated by the massive target retirement series and LifeStrategy from other investors.

This strategy has an arsenal of investment professionals that use a team-based approach with layers of oversight to earn a renewed Above Average People rating.

Vanguard's strategic asset allocation committee oversees the firm’s multi-asset funds. The committee's voting members are senior leaders across the firm, including global head of portfolio construction, chief economist for the Americas, and comanager of Vanguard LifeStrategy Roger Aliaga-Diaz. The firm's investment strategy group, a global network of more than 70 investment professionals, supports the committee. Its research topics range from investor preferences and behavior to portfolio construction.

Michael Roach, head of multi-asset portfolio management, and Aurélie Denis, a portfolio manager in the equity index group, became comanagers in February 2023, joining senior portfolio manager Walter Nejman. This group handles the day-to-day management of the series, including managing cash flows and rebalancing.

Management of the underlying index funds remains stable. Five firm veterans manage the US and international equity funds, including Gerard O'Reilly, Michelle Louie, Nejman, Michael Perre, and Christine Franquin. Joshua Barrickman, head of fixed-income indexing in the Americas, manages the domestic bond strategy independently and the international bond strategy with Tara Talone. Talone was recently added as a comanager on that strategy.

Vanguard maintains its High Parent Pillar rating as it continues to grow under new leadership.

CEO Salim Ramji has had a busy first year captaining Vanguard’s crew, and the ship remains pointed in the right direction. The firm made its largest round of fee cuts in early 2025, which came at an estimated cost of USD 350 million. It established a separate division dedicated to its advice and wealth management efforts, a sign that it wants to seriously compete within those lines of business. Asset growth has continued to be a huge success. Only BlackRock’s inflows rival the money Vanguard is taking in. Likewise, the number of clients it serves has more than doubled since 2015.

Despite that success, an ever-growing number of clients has presented a challenge: Vanguard can’t grow its services fast enough to keep up with demand. In some instances, it has had to curb certain services and capabilities or raise fees on others to cope, causing some loyal clients to criticize what they perceive as deteriorating services.

Vanguard has ambitions to bring its disruptive legacy to the bond market. It created roughly a dozen low-cost bond exchange-traded funds for US investors and several others abroad over the 12 months through June 2025. All have low fees in their respective categories, and the actively managed strategies align with Vanguard’s philosophy. They are relatively easy to understand and are conservatively managed.

Vanguard has another opportunity to prove that clients are still its priority. On the surface, its endeavor into the high-fee deal-making world of private assets alongside Wellington and Blackstone looks like a cultural mismatch. So far, the collaboration hasn’t produced anything that’s concerning.

Well-constructed index components have given LifeStrategy an edge over the long term.

Over the trailing 10 years ended December 2025, the US Growth, Moderate Growth, and Conservative Growth portfolios outpaced their respective category peer averages. On a risk-adjusted basis (as measured by Sharpe ratio), the same outperformers were better than 87% of their category peers on average. The US Income portfolio struggled in this period, trailing the category average by 15 basis points annualized. The lineup of UK-domiciled UCITS did relatively better: Even the worst-performing 20% equity allocation portfolio outpaced two-thirds of peers across the pond.

The index fund building blocks keep each sleeve in line with its market segment, while the underlying asset allocation distinguishes LifeStrategy from competitors. In 2025, the US strategy’s overweighting in non-US stocks versus the category average benefited investors. This contrasted with previous years, when the US funds’ overweighting in non-US stocks versus peers dragged on performance.

LifeStrategy Income underperformed the global-conservative allocation category average when the bond fund’s investment-grade mandate lagged peers with higher credit risk. Outside that segment, the portfolio’s performance strengthened compared with the category average as the equity allocations increased. Historically, the fund's investment-grade-only bond allocation has anchored the strategy during periods of extreme economic uncertainty. However, 2022 was an exception that showed how investment-grade allocations can fail to protect portfolios in unusual market environments. The income portfolio performed worse than global conservative-allocation peers, losing 13% that year versus competitors' 11% loss.

Vanguard LifeStrategy Growth Inv's Prospectus Adjusted Expense Ratio is 0.1% per year. It places it in the cheapest quintile of the Morningstar US Fund Global Moderately Aggressive Allocation Category, where the median fee is 0.94% per year. This cost positioning translates into a Medalist Rating Price Score of 2.47, which reflects its relative price positioning within the category. The Price Score ranges from -2.50 (most expensive) to +2.50 (cheapest), with higher scores indicating better cost competitiveness.